Sales rise 18.07% to Rs 196.75 crore
Net profit of SMS Pharmaceuticals rose 20.20% to Rs 14.10 crore in the quarter ended September 2024 as against Rs 11.73 crore during the previous quarter ended September 2023. Sales rose 18.07% to Rs 196.75 crore in the quarter ended September 2024 as against Rs 166.64 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales196.75166.64 18 OPM %15.9916.69 -PBDT28.1623.06 22 PBT19.5415.16 29 NP14.1011.73 20Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
 "China Taiwan")
 "Lloyd Austin, Lloyd, Austin")
 "Aaditya Thackeray, Aaditya, Thackeray")
 "Donald Trump, Trump")
 "The July Budget made two changes in the treatment of gold that affect investment portfolios. The reduction in import duties to 6 per cent from 15 per cent in the latest Budget lowers input costs for jewellers and compresses margins for smugglers. The")
